The coded price and the uncoded price, together
Each drug is quoted twice in the same sentence: a starting figure, then the same figure with a named discount code applied. That is more honest than printing only the coded number, which is what a reader would otherwise take as the price.
It also means the lower figure depends on a code the seller can retire at any time. The row here carries the uncoded figure as the price and the coded one in the qualifier, because the uncoded one is the rate that survives the promotion.
The seller states that the figure includes the provider consult and free discreet shipping, and that no insurance is required.
The prices live in the legal documents
The passage carrying both drugs' prices renders on the privacy policy and the terms of use as well as the product pages. Every surface agrees, which is more than several sellers on this roster manage across two pages.
Consistency is the strength here. A price repeated identically across five surfaces is a price somebody maintains; a price that differs between the banner and the product page is one nobody owns.
What that consistency cannot supply is an operator. The privacy policy runs to more than nineteen thousand characters of extracted text and contains no company suffix belonging to this business — the only ones present name a drug manufacturer in a trademark disclaimer and an analytics vendor.
A certification claim, repeated
The pages repeatedly describe the business as certified by a named third-party monitoring service. That is the seller's own claim; nothing on the page evidences it, and a certification badge on a page proves that a badge is on a page.
This site does not treat such a claim as verified, and it does not move this row's position either way.
No compounding pharmacy is named, no individual clinician is named, and no service area is published.
AVARA Rx's published pricing
| Medication | Price | Verified |
|---|---|---|
| Semaglutide (compounded) | $229/mostarts at, with the seller adding "$179 with code AVARA50" in the same sentence; the passage carrying this appears on the privacy policy and the terms of use as well as the product pages | September 2026source |
| Tirzepatide (compounded) | $279/mostarting at, or "$229/month with code AVARA50", and the seller states the figure includes the provider consult and free discreet shipping | September 2026source |
compareglp may earn a commission when a reader signs up with a provider through a link on this site. 4 of the 158 providers reviewed here are paid partners today; the other 154 are not. See how this works.
See AVARA Rx's current price →Good fit if
- Readers who want the list price and the coded price stated together by the seller.
- Buyers who want the consult and shipping stated as included rather than assumed.
- People who value a price that reads identically on every page of a site.
Look elsewhere if
- Anyone who wants to know which company they are buying from.
- Buyers who do not want their rate to depend on a discount code.
- Readers who need the pharmacy or the prescriber named.
- People who need a published service area.
How this review was verified
- Read the men's weight-loss page and the privacy policy on 6 September 2026, with a nonsense-path control on the host in the same run that returned a not-found status carrying more than five thousand characters of shell text, so nothing here was judged by response size.
- Searched the full extracted text of the privacy policy for any company suffix and found only a drug manufacturer and an analytics vendor; the absence is recorded as a census.
- Recorded the uncoded figure as the price row and the coded one in the qualifier, because a code can be withdrawn.
- Treated the third-party certification claim as the seller's own assertion and verified nothing from it.
- Screened the operating entity and the brand name against FDA's live warning-letter datatable, carrying a known letter as a positive control and a nonsense string as a negative control in the same pass; the positive control returned its letter and the negative returned nothing. Neither the entity nor the brand returned one. Untitled letters are published separately and were not searched, so the supportable claim is that no warning letter was found.